MedTrace Logo

Monitors to Improve Indoor Carbon Dioxide (CO2) Concentrations in the Hospital

NCT04770597 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2021-05-11

No results posted yet for this study

Summary

Ventilation with fresh outdoor air has recently gained considerable attention as a means to reduce the potential risk of indoor aerosol transmission of respiratory pathogens such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing coronavirus disease 2019 (COVID-19). Commercial carbon dioxide (CO2) monitors are increasingly used in schools, long-term care facilities, offices and public buildings to monitor indoor ventilation. However, no formal evidence is available to support the effectiveness of feedback from CO2 monitoring devices. Moreover, modern hospitals have superior indoor air quality control systems.

The aim of this prospective pilot randomized controlled trial (RCT) is to evaluate whether CO2 monitoring devices would be useful as a means to further maintain lower indoor CO2 concentrations in hospitals.

Conditions

  • Healthcare Associated Infection

Interventions

DEVICE

Aranet4 Home CO2 monitor

The sensor is placed in the room at a height between 1 and 2 meters and not near the window or door.

Sponsors & Collaborators

  • Imelda Hospital, Bonheiden

    lead OTHER

Principal Investigators

  • Michaël R Laurent, MD PhD · Geriatrics Department, Imelda Hospital Bonheiden

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-21
Primary Completion
2021-05-02
Completion
2021-05-02

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04770597 on ClinicalTrials.gov